Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-016045

SVP, Chief Accounting Officer sold 100 shares at $45.65 ($4,565)

  • SVP, Chief Accounting Officer returned 1,333 shares (to the company)
  • SVP, Chief Accounting Officer acquired 7,590 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Huizenga Theodore Alan SVP, Chief Accounting Officer 2023-03-01 Grant or award +7,590 23,148 D
Huizenga Theodore Alan SVP, Chief Accounting Officer 2023-03-01 Sale −100 $45.65 $4,565 23,048 D
Huizenga Theodore Alan SVP, Chief Accounting Officer 2023-03-01 Returned to the company −1,333 $45.65 $60,851 21,715 D
Derivatives
Huizenga Theodore Alan SVP, Chief Accounting Officer 2023-03-01 Grant or award · Stock Option (Right to Buy) +10,120 10,120 D
Open-market sales · 100 sh · avg $45.65 · $4,565
Loading xslF345X03/doc4.xml…